adBlockCheck

Pharmaceutical Company Says Its New Anti-Depressant Is 'Worthless And Dumb'

Top Headlines

Recent News

How Big-Budget Movies Flop

Despite the recent box-office failures of Exodus, Ben-Hur, and Gods Of Egypt, studios continue to fund big-budget movies they hope will achieve blockbuster success. The Onion provides a step-by-step breakdown of how one of these movies becomes a flop:

Study: 96% Of Pickup Games Decided By Next Score

PRINCETON, NJ—Noting that none of the game’s earlier events factored into the final outcome in any way whatsoever, a study released Wednesday by researchers at Princeton University revealed that 96 percent of all pickup games are decided by the next score.

Your Horoscopes — Week Of August 30, 2016

ARIES: Sometimes in life, you just need to stop whatever it is you’re doing and take a step back. Actually, maybe it’s two steps back. Yeah, that’s good. Keep going. The stars will let you know when you’re far enough.

Office Manager Unveils New Rule

WARREN, MI—Stipulating that the regulation would take effect immediately, Summit Industries office manager Angela Werner reportedly unveiled a new rule Tuesday in a company-wide email.

Team Of Vatican Geneticists Successfully Clone God

VATICAN CITY—Describing the groundbreaking work as a major step forward for theological research, a team of Vatican geneticists held a press conference Tuesday at the Apostolic Palace to announce they had successfully cloned God.

What Is The Alt-Right?

A recent speech by Democratic presidential candidate Hillary Clinton criticizing the “alt-right” movement and its support of Republican nominee Donald Trump has shone the national spotlight on the ideologically conservative group. Here’s what you need to know about the alt-right

Aunt On Facebook Casually Advocates War Crime

WILLIAMSPORT, PA—Arguing that it was time to deal decisively with the threat of terrorism, local aunt Deborah Massey casually advocated a war crime Monday in a brief Facebook post, sources confirmed. “Any city that has ISIS people hiding out in it needs to be bombed to the ground.

Dad Shares Photo Album Through Never-Before-Seen Website

SECAUCUS, NJ—Wondering aloud how the father of three even managed to find the online image-hosting service, family members of local dad Phil Yates told reporters Monday the 57-year-old had shared a photo album with them through a never-before-seen website.

How Obamacare Can Be Improved

With Aetna just the latest health insurance provider to opt out of covering Obamacare markets, many are wondering what changes can make the Affordable Care Act more appealing to customers and insurance companies. Here are some proposed improvements
End Of Section
  • More News
Up Next

Pharmaceutical Company Says Its New Anti-Depressant Is 'Worthless And Dumb'

EAST BRUNSWICK, NJ—At a press conference Monday, Peter Cafazzo, CEO of Brunley-Hunt Pharmaceuticals (BHP), introduced his company's latest anti-depressant, Cyntrex, a product he described as "a totally stupid waste of time that probably nobody will ever want ever."

Peter Cafazzo, CEO of Brunley-Hunt Pharmaceuticals, unveils Cyntrex, a "worthless new drug" that he says will make the company "the total laughingstock of the industry."

Though from the outset, BHP had hoped the new medication would revolutionize the treatment of depression, Cafazzo is less than enthusiastic about its chances against such industry leaders as Prozac and Zoloft.

"Cyntrex? Yeah, right. More like, Stupidtrex," a visibly downcast Cafazzo told reporters. "More like, Another-Awful-Product-That-Will-Probably-Make-Us-All-Bankruptrex. More like, I suck."

The new drug, which stimulates the production of neurotransmitters in sync with the body's natural diurnal catecholamine rhythms—causing a more even mood level than the frequent "crest and trough" patterns associated with traditional psychoactive medicinal treatments—is something that "everybody will laugh at," Cafazzo said.

Among the reasons Cafazzo cited for Cyntrex's "totally doomed future" is BHP's inability to do anything half as well as its chief competitors.

"Prozac is so great," Cafazzo said. "We'll never make anybody as happy as Prozac does. I just know it."

Added Cafazzo: "My life is shit."

The release of Cyntrex is the latest bold move by BHP, which has increased its share of the mental-health drug market from 7 to 11 percent during the five years Cafazzo has been the company's CEO, causing many to view BHP as the rising giant in $150 billion pharmaceutical industry.

Cafazzo, however, questions the validity of such an appraisal. "Eleven percent? Oh, I'm sure. Like a company's really going to do that well with such a total fucking loser asshole for a boss."

"Maybe I'll get a raise," he said. "Then I can use the money to buy a gun to blow my head off."

According to reports, top BHP researchers began having doubts about the drug during the early development stages, when they realized they couldn't do anything right ever ever ever, and that none of the pharmaceutical-industry leaders cared whether they lived or died. But work on the project continued, despite BHP's growing conviction that Cyntrex would be the worst product in pharmaceutical history.

"We should have just stopped trying back then during the development stage," BHP lab assistant Peter Ayers said. "But, no, we had to go and make ourselves look like idiots in front of the whole world. Us and our lousy little pills both. Why?"

Ayers then began beating his fists into the sides of his head while staring at the floor, repeating, "Why? Why, why, why, why, why?" before being restrained by loved ones.

Fellow BHP researcher Harlan Downing said that, in addition to treating depression, Cyntrex may have numerous other uses. "There is a strong possibility," Downing said, "that the particular disinhibitors activated by Cyntrex may be of great benefit in the treatment of Alzheimer's Disease." He then admitted that the drug will not be ready for such use for some time, repeatedly hitting his forehead into a wall and gently mumbling under his breath.

BHP's chief rival in the mood-altering drug field is Stafford Labs, manufacturer of Prozac. Stafford CEO Margaret Curry expressed faith that Prozac would maintain its position despite the new competition.

"We will emerge triumphant, for I am Margaret Curry, president of Stafford Labs!" she said. "My power is as of 50 CEOs! My marketing savvy is as of a legion of PR firms! My tricyclic monoinhibitor is a boon unto the people and a beacon unto the nations! My new promotional campaign to enhance brand awareness and increase market saturation of Prozac shall be cloaked in radiant beams of persuasive glory!"

Sign up For The Onion's Newsletter

Give your spam filter something to do.

X Close